Eric Dimise, PhD, is Director, Healthcare & Life Sciences, Capital Markets NYSE Group, a part of Intercontinental Exchange, Inc. (NYSE: ICE). Eric is responsible for attracting new listings from companies within the healthcare and life sciences industry. He advises companies, private equity and venture capital firms, investment bankers, and other key stakeholders on the IPO landscape, NYSE initiatives, and listing venue selection. Prior to joining NYSE, Eric served as Vice President and Team Lead of Healthcare Content and Events at Gerson Lehrman Group (GLG), overseeing a team that curated market-driven events for investor clients with coverage in the pharmaceutical, biotechnology, and medical device and diagnostics sectors. Before GLG, Eric worked as a Cardiovascular and Metabolic Disease Analyst at GlobalData. He completed his doctoral training in Chemistry at Boston College and a postdoctoral research fellowship at Harvard Medical School. While in academia, Eric’s research focused on natural product and synthetic organic chemistry as well as microbial communication in the environment and the human microbiome.